Elite athletes and the gene for angiotensin-converting enzyme
Open Access
- 1 September 1999
- journal article
- clinical trial
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 87 (3), 1035-1037
- https://doi.org/10.1152/jappl.1999.87.3.1035
Abstract
The deletion (D) allele of the gene for angiotensin-converting enzyme (ACE) is associated with higher plasma and tissue levels of the enzyme and has also been related to a variety of cardiovascular complications, particularly myocardial infarction. On the basis of indirect evidence, we hypothesized that inheritance of the D allele would contribute to elite athletic ability. Over a period of 4 yr, 120 Caucasian athletes who were national (Australian) representatives in sports demanding a high level of aerobic fitness were recruited. Their ACE genotypes were compared with those of a community control group recruited randomly from the electoral roll. There was no difference in ACE genotype frequencies between the two groups. The DD genotype frequency was 30% in athletes and 29% in the control group, and the II genotype frequency was 22.5 and 22%, respectively. The results do not exclude the possibility that ACE genotype could be related to some attribute relating to a specific type of elite athletic ability or that there may be a difference between genders. Larger studies are desirable.Keywords
This publication has 19 references indexed in Scilit:
- ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlandersThe Lancet, 1999
- Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical trainingThe Lancet, 1999
- Human gene for physical performanceNature, 1998
- Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.Journal of Clinical Investigation, 1995
- Angiotensin-Converting Enzyme in the Human HeartCirculation, 1995
- The role of the renin‐angiotensin and natriuretic peptide systems in the pulmonary vasculature.British Journal of Clinical Pharmacology, 1995
- Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.Circulation Research, 1993
- Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.Journal of Clinical Investigation, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990